research use only
Cat.No.S8361
| Related Targets | PD-1/PD-L1 CXCR STING AhR Immunology & Inflammation related CD markers Interleukins Anti-infection Antioxidant COX |
|---|---|
| Other CCR Inhibitors | Cenicriviroc Vicriviroc Malate Adaptavir (DAPTA) ZK756326 2HCl SB-297006 INCB3344 RS102895 Vicriviroc maleate AZD2098 R243 |
|
In vitro |
DMSO
: 100 mg/mL
(175.87 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 568.59 | Formula | C29H31F3N6O3 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 857679-55-1 | -- | Storage of Stock Solutions |
|
|
| Synonyms | INCB8761, PF-04136309 | Smiles | OC1(CCC(CC1)NC2CCN(C2)C(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)C4=NC=C(C=C4)C5=NC=CC=N5 | ||
| Targets/IC50/Ki |
CCR2
5.2 nM
|
|---|---|
| In vitro |
PF-4136309 is potent in inhibiting CCR2 mediated signaling events such as intracellular calcium mobilization and ERK (extracellular signal-regulated kinase) phosphorylation. <sup><a class="sref" href="#s_ref">[1]</a></sup> |
| In vivo |
PF-4136309 exhibits >100-fold selectivity over other homologous chemokine receptors, a free fraction of 24% in human serum and 15% in mouse serum, and an oral bioavailability of 47% in mice, suitable as a tool compound for target validation in rodent models.<sup><a class="sref" href="#s_ref">[2]</a></sup> |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.